Taihe Group Inc.
Taihe Group, Inc. does not have significant operations. It intends to develop and construct lands and properties relating to tourism integrating real estates and villas. The company was formerly known as NuOncology Labs, Inc. and changed its name to Taihe Group, Inc. in April 2022. Taihe Group, Inc. was incorporated in 1994 and is based in Bintan, Indonesia.
Taihe Group Inc. (TIHE) - Net Assets
Latest net assets as of March 2023: $-63.15K USD
Based on the latest financial reports, Taihe Group Inc. (TIHE) has net assets worth $-63.15K USD as of March 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($0.00) and total liabilities ($63.15K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-63.15K |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Taihe Group Inc. - Net Assets Trend (2020–2022)
This chart illustrates how Taihe Group Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Taihe Group Inc. (2020–2022)
The table below shows the annual net assets of Taihe Group Inc. from 2020 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-43.97K | -- |
| 2021-12-31 | $0.00 | -- |
| 2020-12-31 | $0.00 | -- |
Equity Component Analysis
This analysis shows how different components contribute to Taihe Group Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7318600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $10.00K | % |
| Other Components | $10.84 Million | % |
| Total Equity | $-43.97K | 100.00% |
Taihe Group Inc. Competitors by Market Cap
The table below lists competitors of Taihe Group Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LPSB3F
SA:LPSB3F
|
$2.88K |
|
TRANS.EVERGR. INH. EO -5
F:36J
|
$2.88K |
|
RHT HOLDING LTD
SEM:RHT
|
$2.88K |
|
Taaleem Management Services
EGX:TALM
|
$2.89K |
|
Wynnstay Properties PLC
LSE:WSP
|
$2.87K |
|
Raku Co., Ltd
TWO:4154
|
$2.87K |
|
CITIC TELECOM
MU:B7O
|
$2.87K |
|
Inspiration Healthcare Group PLC
LSE:IHC
|
$2.87K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Taihe Group Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -10,837,376 to -43,967, a change of 10,793,409.
- Net loss of 43,967 reduced equity.
- Other factors increased equity by 10,837,376.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-43.97K | -100.0% |
| Other Changes | $10.84 Million | +24648.89% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Taihe Group Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $-3332.93 | $1.00 | x |
| 2021-12-31 | $-2775.26 | $1.00 | x |
| 2022-12-31 | $0.00 | $1.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Taihe Group Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $1.05 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-39.57K |
Industry Comparison
This section compares Taihe Group Inc.'s net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Taihe Group Inc. (TIHE) | $-63.15K | 0.00% | N/A | $2.87K |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |